Home API Alogliptin Benzoate

Alogliptin Benzoate

Enquire Now

[anr_nocaptcha g-recaptcha-response]

What is Alogliptim Benzoate?

Alogliptin is a selective, orally bioavailable dipeptidyl peptidase-4 (DPP-4) inhibitor. It increases the amount of insulin produced by your body. Besides controlling Type-2 diabetes, Alogliptin Benzoate may also eliminate the cardiovascular disease by preventing the toll-like receptor 4 (TLR-4). These receptors can increase the chances of inflammation, further increasing the atherosclerotic disease process, the main cause of cardiovascular disease. 

Product Description

Molar Weight: 339.4



ALogP: 0.39

Solubility: DMF: 0.1 mg/ml, DMSO: 0.1 mg/ml, Ethanol: slightly soluble, PBS (pH 7.2): 10 mg/ml

Storage: -20°C

Stability: ≥ 2 years

CAS Number: 850649-62-6

Chemical Formula: C18H21N5O2•C7H6O2

Therapeutic Category: Antidiabetic

Form: Tablet

Assay: NLT 99.0%

Suitable for: Adults

IUPAC Name: 2-({6-[(3R)-3­aminopiperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl}methyl)benzonitrile monobenzoate


Alogliptin Benzoate

Approved Indications: 1

As per the clinical trials, there is one approved indication of Alogliptin Benzoate drug:

  • Diabetes Mellitus, Type-2

Experimental Indications: 7

As per clinical trials 1-4, the drug can be used in the following categories: 

  • Acute Coronary Syndrome (Phase 3)
  • Diabetes Mellitus ()
  • Diabetes Mellitus, Type 2 ()
  • Healthy Volunteers (Phase 1)
  • Non-alcoholic Fatty Liver Disease (Phase 4)
  • Pharmacokinetics (Phase 1)
  • Pharmacology, Clinical (Phase 3)

Clinical Trials:

A total of 60 trials took place in 4 phases. 13 organizations participated in these trials.

Side Effects

Major side effects observed after the consumption of Alogliptin are:

  • Upper respiratory tract infection
  • Common cold
  • Headache


Alogliptin Benzoate is an orally bioavailable dipeptidyl peptidase 4 (DPP-4) inhibitor used to treat type-2 diabetes. The drug has a molar mass of 339.4 g/mol and does not inhibit cytochrome P450 enzymes. The drug is actively used in making medications for type-2 diabetes patients. Besides that, it also has several other experimental indications, including Acute Coronary Syndrome, Non-alcoholic Fatty Liver Disease, etc. Some common side effects are headaches and the common cold.

Product CAS No


Therapeutic Action

Alogliptin increasing the amount of insulin in our body, which is a type of hormone that control sugar leval in our blood in people with type 2 diabetes, also help prevent kidney damage.

Enquire Now
close slider

[anr_nocaptcha g-recaptcha-response]